JMT-203

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameJMT-203
Drug Alias NameJMT203JMT-203
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionGDNF family receptor alpha-like antagonists
TargetsGDNF family receptor alpha-like
Therapy Area/IndicationsCachexiaCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Jmt-Bio Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Jmt-Bio Inc
Inactive CompaniesN/A
Active IndicationsCachexiaCarcinoma, Non-Small-Cell LungPancreatic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A